UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010743 |
|---|---|
| Receipt number | R000012084 |
| Scientific Title | Analysis of immunological status using CFSE-MLR for de-novo kidney transplant recipients who are treated with Everolimus commencing 3 months after surgery. |
| Date of disclosure of the study information | 2013/05/16 |
| Last modified on | 2020/03/11 21:02:49 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/05/16 16:03:48 | ||
| 2 | Update | 2014/05/17 10:55:53 | TEL Last name of contact person Last name of contact person Address Address TEL Organization1 Tel1 Email1 |
|
| 3 | Update | 2014/05/17 10:58:59 | Recruitment status |
|
| 4 | Update | 2018/05/17 20:32:30 | Randomization unit Stratification Dynamic allocation Institution consideration Blocking Concealment |
|
| 5 | Update | 2018/05/17 20:33:40 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 6 | Update | 2018/06/12 21:16:49 | UMIN ID1 |
|
| 7 | Update | 2018/11/22 09:13:07 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 8 | Update | 2020/03/11 20:44:31 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2020/03/11 20:59:19 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 10 | Update | 2020/03/11 21:02:49 | Recruitment status Date of IRB Anticipated trial start date |
